Cidara Therapeutics Investor Relations Material

Cidara Therapeutics Inc. is a biotechnology company focused on developing anti-infective and immunotherapy treatments. The company specializes in long-acting antifungal and antiviral therapies, utilizing its proprietary drug-Fc conjugate (DFC) platform to enhance targeted immune responses. Its pipeline includes investigational treatments for serious fungal infections and viral diseases. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.